Industry
Chengdu Qingshan Likang Pharmaceutical Co., Ltd
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed trials have results
Key Signals
2 recruiting
Enrollment Performance
Analytics
Phase 3
1(33.3%)
Phase 4
1(33.3%)
N/A
1(33.3%)
3Total
Phase 3(1)
Phase 4(1)
N/A(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT07550894Phase 3Not Yet Recruiting
Phosphate-Containing Replacement Fluid for Patients Undergoing CRRT
Role: collaborator
NCT07077538Not ApplicableRecruiting
Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients
Role: collaborator
NCT06597201Phase 4Recruiting
Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.
Role: lead
All 3 trials loaded